etonogestrel · Organon · NDA 021529
Nexplanon
Earliest generic entry, as listed
28 Jul 2030
Blocked by patent: US 9757552.
Listed patents · 3 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 9757552 | product, use U-1 | 28 Jul 2030 |
| US 8722037 | product | 28 Sep 2027 |
| US 10821277 | product | 31 May 2027 |
Exclusivities · 1 unexpired
| D-199 | new dosing schedule | 16 Jan 2029 |
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 021529 · 002 · RLD | implant, implantation | 68MG/IMPLANT | 28 Jul 2030 |
Expired or delisted (1)
- US 8888745 · product · 28 Aug 2026